This actually worries me.
Animas (PUMP ), a little-known maker of small glucose pumps -- to let diabetics constantly monitor the sugar in their blood -- could take a big share of the insulin-measurement market. So say two New York hedge-fund managers, who have bought shares. Animas pumped up from 12 in August to 19.31 in early February, before easing to 18.74.